Visalytics
Visalytics
approved EB-2 (NIW)

Researcher

Biomedical Research · Iran · 2025-01-25

Processing Time
279 days
Decision Date
2025-01-25
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to design, construct, and characterize molecular robots that detect specific microRNA molecules as cancer markers to provide inexpensive and fast diagnostic tools. Her work focuses on pioneering efficient molecular robot core designs that protect nucleic acids and trigger controlled release into specific cells for improved biocompatibility in cancer therapy.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses the financial burden of cancer and the need for faster, more efficient diagnostic and treatment tools using nanotechnology.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic background, 349 citations, and 16 peer-reviewed publications indicate a high level of expertise and influence in the field.

3 Waiver Benefit Met

The petitioner's contributions to nanoparticle optimization and molecular robots make her an invaluable asset to U.S. biomedical interests, justifying the waiver of a job offer.

Why This Petition Was Approved

The petitioner satisfied the Dhanasar framework through her Ph.D. in biotechnology, a record of 16 peer-reviewed journal articles, and 349 citations. Her expertise was further validated by 6 peer review invitations for elite journals and support from four expert scholars confirming her role in advancing nanoparticle optimization.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Reference Letters Independent
Reference Letters Dependent
Original Contributions
Conference Presentations

Similar Cases

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
162 days 2025-04-17
The petitioner proposes to continue his research in molecular biomedicine, specifically focusing on the development of nanoparticle-based delivery systems. His work aims to improve targeted cancer therapies, including chemotherapy, immunotherapy, and tumor thermal therapy, to enhance therapeutic efficacy while reducing side effects. The intended impact is to advance cancer care and oncology breakthroughs within the U.S. healthcare system.
View Case

Postdoctoral Researcher

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Ohio 112 days 2023-02-07
The petitioner proposes to continue research on utilizing biomedical engineering in cancer research and development to improve health outcomes for patients. The work focuses on nanotechnology for drug delivery, the exploration of circulating tumor cells (CTCs), and the creation of microfluidic models to inform metastasis research.
View Case

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 309 days 2025-04-01
The petitioner proposes to continue research in the United States focused on synthesizing tumor-targeted nanocarriers for RNA therapeutic delivery and improving mRNA purification systems. This work aims to develop cost-effective and scalable solutions for cancer vaccines and RNA-based therapies. The endeavor is designed to address critical challenges in cancer therapy and vaccine manufacturing.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Florida 48 days 2025-09-04
The petitioner proposes to develop precision oncology tools by integrating nanotechnology, immunology, and computational methods to engineer next-generation cancer therapies. His work specifically focuses on designing personalized, neoantigen-based nano vaccines and SMART-lipid nanoparticles to improve immune system responsiveness and overcome tumor immune evasion.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-01-25.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 279 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist